High efficacy of HPV 16/18 AS04-adjuvanted vaccine shown against CIN2+ associated with HPV-16/18 and non-vaccine oncogenic HPV types.
Rambout
Lisa
L
Division of Gynaecologic Oncology, Department of Pharmacy, The Ottawa Hospital, General Campus, Ottawa, Ontario, Canada K1H 8L6. lrambout@toh.on.ca